A microfluidic system for monitoring glucagon secretion from human pancreatic islets of Langerhans

7Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.

Abstract

Glucagon is a 29-amino acid peptide released from α-cells within pancreatic islets of Langerhans to help raise blood glucose levels. While a plethora of methodologies have been developed for quantitative measurement of insulin released from islets, such methods are not well developed for glucagon despite its importance in blood sugar regulation. In this work, a simple yet robust microfluidic device was developed for holding human pancreatic islets and perfuse them with glucose. The perfusate was collected into 2 min fractions and glucagon quantified using a homogeneous time-resolved Förster resonance energy transfer (TR-FRET) sandwich immunoassay. Simulation of fluid flow within the microfluidic device indicated the device produced low amounts of shear stress on islets, and characterization of the flow with standard glucagon solutions revealed response times within 2 fractions (<4 min). Results with human islets from multiple donors demonstrated either a "burst"of glucagon or a "sustained"glucagon release across the entire period of stimulation. The simplicity, yet robustness, of the device and method is expected to appeal to a number of researchers examining pancreatic islet physiology.

Cite

CITATION STYLE

APA

Eaton, W. J., & Roper, M. G. (2021). A microfluidic system for monitoring glucagon secretion from human pancreatic islets of Langerhans. Analytical Methods, 13(32), 3614–3619. https://doi.org/10.1039/d1ay00703c

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free